Our Mission
CrystecPharma is a global pharmaceutical technology company focused on transforming the performance of medicines.
Our scalable mSAS® particle engineering technology optimises new and existing small and large molecule therapeutics, enhancing drug delivery, stability and efficacy.
We enable medicines to be developed with patients in mind. Our mission is to ensure that, however administered, every therapeutic achieves its full potential, with fewer side effects and at lower cost.
We are committed to industry-leading development speed, expanding access to convenient and affordable medicines, reducing reliance on refrigeration, and advancing green pharmaceutical manufacturing.
CrystecPharma. Performance in every particle.
mSAS® Technology
Performance in Every Particle®
The Crystec team have pioneered the development of mSAS®, a modified Supercritical Anti-Solvent process. mSAS® is a powerful technology for engineering particles to improve the bioavailability, stability, and delivery of small molecule and large molecule therapeutics.
This unique platform enables the size and shape of particles to be finely tuned. Where required, more than one drug can be combined in a particle, or excipients incorporated in the particle to further enhance performance and reduce manufacturing complexity. We design particles with the medicine in mind, hence Performance in Every Particle®.
mSAS® Technology
in Action
Precise engineering of particles using mSAS® technology can greatly improve how drug molecules dissolve, the purity of medicines, their ease of processing, flow and aerosolisation.
This short video demonstrates the level of performance that can be achieved with mSAS®.
AI Accelerated Product Development
Discover our Latest News
September 1, 2026
August 27, 2026
August 10, 2026
Follow us on LinkedIn to stay up to date with news, articles, updates and more
Schedule a Meeting
Contact our team today to see how CrystecPharma’s technology and expertise could revolutionize your pharmaceutical program.
